Week 316 Review - Big surges for Jubilee Metals and 4D Pharma

A pretty good week, with gains for my biggest holdings resulting in a narrowing of the deficit between cost and value of £4,880 to £22,604 and an increase in total portfolio value to £124,911.

The only big loser this week was TLOU:Tlou Energy, which has been on a good run recently and I think suffered some profit taking. They dropped 9% in my SIPP and are no longer in profit. I think this needs the PPA to be signed with the Botswanan government before a real re-rate happens. The share price is 3p and my options are for 4p so I'm hoping by the time I can take advantage of them the price will be a lot higher.

ASHM:Ashmore Group climbed by 5% and went back into profit. This is just quietly being a good magic formula share. The dividend isn't due till November so I'm hoping they will climb a bit before then so they stay in profit on ex-dividend day.

CAML:Central Asia Metals regained some of last week's losses with a 6% rise to go 25% in profit. I wish I had more of these at the current price, but my sales have enabled a much more diverse portfolio so I think it was the right thing to do.

FXPO:Ferrexpo also recovered a chunk of last week's losses and increased by 7%, but such has been the crash over the last few weeks that I am still 15% down. A nice dividend arrived this week though.

DDDD:4D Pharma is my 2nd largest holding, so much of this week's gains were due to the 10% climb. I'm still down by 27% but there's some momentum now, and news is expected soon which should cause a big spike.

Share of the Week is JLP:Jubilee Metals which announced a new deal to re-open a refinery and fast-track copper earnings in Zambia. That caused an impressive recovery after the recent slump, and the shares rose by 76% of my original purchase price to go 304% up.

Much closer to the cost line than the injection line and at the highest value for over 6 months. Thank goodness summer holidays are over!

Soaring above the trend line, but how long can we stay there?

Here's the ISA and shares portfolio after week 4 of year 7.

			Weekly Change
Cash	£31.58		+£0
Portfolio cost	£68,170.47		+£0
Portfolio sell value (bid price-commission)	£60,030.62	(-11.9%)	+£3,015.40
Potential profits	£6,574.08		+£1,650.00
Yr 7 Dividends	£0		+£0
Yr 7 Profit from sales	£0		+£0
Yr 7 projected avg monthly profit	£0	(0%)	+£0
Total Dividends	£1,343.15		+£0
Total Profit from sales	£24,123.94		+£0
Average monthly cash profit	£345.37	(9.4%)	-£1.10
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	57%		+0%

Huge rise in potential profits of £1,650 all thanks to JLP:Jubilee Metals. a 1p gain in OPTI:Optibiotix contributed to the £3,015 increase in value, as did the big rise in DDDD:4D Pharma. Long term performance slipped another 0.1% to 9.4% so I could do with selling something. I don't want to sell any JLP, so my only real hope is my share account holding of OPTI:Optibiotix which I plan to sell at 84p and transfer the original cash into my trading account and the profits into my ISA. I may do it a little at a time if there's still upwards momentum, as I won't be able to find trading shares to buy with all £2,500 at once. It does mean paying more commission though.

Looking more promising

Trend line is upwards, and we're above it!

The SIPP looks like this after week 300 overall and week 40 of year 6.

			Weekly Change
Cash	£338.33		+£41.81
Portfolio cost	£76,342.81		+£0
Portfolio sell value (bid price - commission)	£62,861.97	(-17.7%)	+£1,745.01
Potential profits	£369.26		+£19.98
Yr 6 Dividends	£944.58		+£41.81
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£8,345.60		+£0
Yr 6 projected avg monthly profit	£990.09	(25.9%)	-£20.75
Total Dividends	£3,011.66		+£41.81
Total Interest	£0.20		+£0
Total Profit from sales	£23,805.04		+£0
Average monthly cash profit	£376.21	(9.8%)	-£0.65
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	57%		+0%

Cash increased by £41 thanks the the FXPO:Ferrexpo dividend, portfolio value up by £1,745 mostly thanks to DDDD:4D Pharma and OPTI:Optibiotix, and potential profits only sneaked up by £19 thanks to the big drop in TLOU:Tlou Energy.

Only just above halfway between injection and cost, so quite a way to go.

Back above the trend line, but it's going to take a lot to reverse the direction.

The trading account looks like this after week 266 overall and week 6 of year 6.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£1,389.94	(-41.5%)	+£121.43
Potential profits	£0.00		+£0
Year 6 Dividends	£0.00		+£0
Year 6 Profit	£0.00		+£0
Yr 6 projected avg monthly profit	£0.00	(0%)	+£0
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£16.26	(8.2%)	-£0.06
(Sold stocks profit + Dividends - Fees / Months)

One of the best ever weeks, with all shares increasing in value and £121 of my losses got back.

Back on the right side of the injection line but a long, long way to go 

Although it was a good week, we're still well below the trend line, but it's September now and news is expected for DDDD:4D Pharma, and HUM:Hummingbird Resources may benefit if there's a bullish run on gold miners. Still looking hopeless for IQE:IQE, and if their recent newsletter is to be believed,  TALY:Tally should re-list in December.

I just had a look at my SIPP portfolio and I'm now up to 10 magic formula shares, all paying good dividends. There seems to be a rush of them in October, so something to looks forward to. Only 3 of the 10 are in profit, so I'm not doing as well as last year, but the earliest review date is the end of May next year, so there's plenty of time. Currently £10,000 worth of shares are down by £865, but most of those losses are down to the recent bear run on miners.

Last year's batch made me £2,500 profit from 5 companies costing £5,000 so a pretty staggering 50%, along with an additional £384 in dividends, which is 7.6%. Given ITV:ITV didn't pay a dividend, the return from dividend-paying companies was actually 9.6%. If I can get anywhere near that sort of performance with my new batch then I'd be able to say the formula is working. 

Week 315 Review - Miners crash but Optibiotix rallies

Generally this was a reasonable week, but my miners took a big hit. Thankfully OPTI:Optibiotix had a rally on Friday and ended the week 3p higher, which is worth £4,800 and blotted out the effect of the drop in miners, so the week finished with the deficit between cost and value narrowed by £3,944 to £27,485 and total portfolio value up to £119,989.

Biggest faller for the 2nd week in a row was JLP:Jubilee Metals, down 23% of my original purchase price costing £500 to potential profits. I don't know why these are caught up in the miner malaise, as they are such low cost producers they will still make huge profits at the current metals prices.

FXPO:Ferrexpo dropped even more than last week when they went ex-dividend, falling 11% this week to go 22% down since I bought them. They were in profit a few weeks ago so this has been an absolute hammering.

CAML:Central Asia Metals are another low cost producer that were caught up in the metals slide, falling 10% this week. They are still 19% up overall, but I'm glad I took out some profits before the drop. If they fall any further I'll be wanting to buy some more.

OPTI:Optibiotix are getting a bit more momentum, climbing 5% this week. I think there's a growing sense of anticipation that Sweetbiotix news isn't far away, and when that hits we'll need to buckle up.

Share of the Week is PLUS:Plus500 which climbed 8% and is only 5% down now. The rise came on a good trading update and nice hike to the dividend, so I'm hopeful these will be one of the more well behaved magic formula shares.

Not quite back up to where we were 2 weeks ago, but not far short.

Back to being tantalisingly close to crossing the trend line

Here's the ISA and shares portfolio after week 3 of year 7.

			Weekly Change
Cash	£31.58		+£0
Portfolio cost	£68,170.47		+£0
Portfolio sell value (bid price-commission)	£57,015.22	(-16.4%)	+£1,932.83
Potential profits	£4,924.08		-£500.00
Yr 7 Dividends	£0		+£0
Yr 7 Profit from sales	£0		+£0
Yr 7 projected avg monthly profit	£0	(0%)	+£0
Total Dividends	£1,343.15		+£0
Total Profit from sales	£24,123.94		+£0
Average monthly cash profit	£346.47	(9.5%)	-£1.10
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	57%		+0%

£500 drop in potential profits thanks to JLP:Jubilee Metals, but £1,932 better off despite this. Long term performance holding up but no prospect of selling anything for a while.

Still trapped in the channel

A good week next week and we may cross the trend line

The SIPP looks like this after week 299 overall and week 39 of year 6.

			Weekly Change
Cash	£296.52		+£0
Portfolio cost	£76,342.81		+£0
Portfolio sell value (bid price - commission)	£61,116.96	(-19.9%)	+£2,047.24
Potential profits	£349.28		-£38.30
Yr 6 Dividends	£902.77		+£0
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£8,345.60		+£0
Yr 6 projected avg monthly profit	£1,010.84	(26.5%)	-£26.60
Total Dividends	£2,969.85		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£23,805.04		+£0
Average monthly cash profit	£376.86	(9.9%)	-£1.26
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	57%		+0%

Profits slightly down thanks to the big hit on CAML:Central Asia Metals and ASHM:Ashmore Group went back to a loss too. Better news for IGG:Ig Group which climbed to £62 (6%) profit, and TLOU:Tlou Energy which also went back to profit by £69 (3%). Long term performance is good enough not to want to sell anything.

Looking a bit more promising.

So close to getting back above the trend line.

The trading account looks like this after week 265 overall and week 5 of year 6.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£1,268.51	(-46.6%)	-£36.78
Potential profits	£0.00		+£0
Year 6 Dividends	£0.00		+£0
Year 6 Profit	£0.00		+£0
Yr 6 projected avg monthly profit	£0.00	(0%)	+£0
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£16.32	(8.2%)	-£0.06
(Sold stocks profit + Dividends - Fees / Months)

Everything dropped in value this week so no sign of hope or optimism.

It's happened - we've dropped below the injection line - I may as well not have bothered!

The trend line is getting steeper every week as the fall continues.

If the current metal price malaise continues then it's not looking great for some of my biggest holdings, but there are metal shortages and production is still way below demand, so I can't see this decline continuing. The other thing I desperately need is some news from DDDD:4D Pharma, as they are my 2nd biggest holding and are down by 40% with a deficit of £5,600. Recovering that would do an awful lot to get me into a respectable position. It just needs one bit of good news...

Week 314 Review - Dreadful week losing much of last week's recovery

A rubbish week with nearly everything dropping and the few that rose were tiny increases in value. Roll on September! The deficit between cost and value widened by £4,353 and only £3,200 of that was down to OPTI:Optibiotix. That set the deficit at £31,430 and reduced total portfolio value to £116,044.

Worst performer was JLP:Jubilee Metals which inexplicably fell 44% of my original purchase price wiping out £950 of potential profits. They are still 250% up though, and still my only profitable ISA share.

FXPO:Ferrexpo went ex-dividend, but continued to drop even after that to lose 7% this week and go 11% down altogether. My new crop of magic formula shares are definitely struggling compared to the last lot, and FXPO was one of the original lot that I bought back into after banking 95% profit.

Share of the week only climbed 3% which shows what a bad week it was. TLOU:Tlou Energy are very close to being in profit in my SIPP holding, only £1 (0%) down. The ISA holding has a lot further to go, as that's 57% down. I still keep the faith with these and may get some more.

The drop doesn't look as bad on this chart compared to the fluctuations over the last 6 months.

Not as low as a few weeks ago, but failing to get above the trend line.

Here's the ISA and shares portfolio after week 2 of year 7.

			Weekly Change
Cash	£31.58		+£0
Portfolio cost	£68,170.47		+£0
Portfolio sell value (bid price-commission)	£55,082.39	(-19.2%)	-£2,533.50
Potential profits	£5,424.08		-£950.00
Yr 7 Dividends	£0		+£0
Yr 7 Profit from sales	£0		+£0
Yr 7 projected avg monthly profit	£0	(0%)	+£0
Total Dividends	£1,343.15		+£0
Total Profit from sales	£24,123.94		+£0
Average monthly cash profit	£347.57	(9.5%)	-£1.11
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	57%		+0%

Not much happening other than a huge drop in potential profits thanks to JLP:Jubilee Metals and the bulk of the other losses were from OPTI:Optibiotix falling 2p.

Back to being halfway between cost and injection lines

So close to crossing the trend line but thwarted.

The SIPP looks like this after week 298 overall and week 38 of year 6.

			Weekly Change
Cash	£296.52		-£8.09
Portfolio cost	£76,342.81		+£391.10
Portfolio sell value (bid price - commission)	£59,069.72	(-22.6%)	-£1,810.23
Potential profits	£387.58		-£186.81
Yr 6 Dividends	£902.77		+£0
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£8,345.60		+£263.01
Yr 6 projected avg monthly profit	£1,037.44	(27.1%)	+£2.77
Total Dividends	£2,969.85		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£23,805.04		+£263.01
Average monthly cash profit	£378.12	(9.9%)	+£2.56
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	57%		+1%

I updated my magic formula spreadsheet last week and a new stock shot to number 4 in the rankings. SMS:Smart Metering Systems has a P/E ratio of just 5.24 ranking it 46th, pays a 3% dividend ranking it 110th, has a return on capital employed of 46.5% ranking it 10th, and has a debt to profit ratio of just 0.29% ranking it 14th. With figures that outstanding I had to add it to my portfolio, as it's better than most of my existing magic formula shares.

I sold 400 of my CAML:Central Asia Metals shares for £263.01 (35.2%) profit. That liberated almost £1,000 and left me with 600 CAML shares. As these cost me £1,147 it brings them in line with my other magic formula shares and helps spread the risk of having too much in one miner, something I'm keen to pursue after the dam leak CAML had last year, which showed even the best mining companies can suffer a disaster.

I bought 107 SMS:Smart Metering Systems shares at 927.485p costing £1,004.36. With spread and commission they are down 3%. They usually pay a dividend in October, so not long to wait for that.

I also set up a monthly savings plan for £120 per month, and that kicked in for the first time this week. I bought 5.16 units of the Blackrock Word Gold fund for 2,325.581p. That's down 1% by the end of the week. I'll keep adding to this every month as my gold hedge and slowly phase out my investments in higher risk single mining companies.

Potential profits didn't drop as far as the money I banked, as ASHM:Ashmore Group climbed 1% and IGG:IG Group climbed 2% to help make up some of the deficit. Long term performance improved by £2 a month but I can't quite do enough to get it back to 10%.

Not too much of a dip.

That looks a bit worse. How I dream of being back above the tend line.

The trading account looks like this after week 264 overall and week 4 of year 6.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£1,305.29	(-45.0%)	-£10.07
Potential profits	£0.00		+£0
Year 6 Dividends	£0.00		+£0
Year 6 Profit	£0.00		+£0
Yr 6 projected avg monthly profit	£0.00	(0%)	+£0
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£16.38	(8.3%)	-£0.06
(Sold stocks profit + Dividends - Fees / Months)

Not much change here, with value slipping yet again, but by just £10.

The value line is almost touching the injection line. In just over 5 years I've managed to end up with exactly the same amount I put in. What a roaring success!

Down to a new 12-month low. With 2/5 of the portfolio invested in DDDD:4D Pharma I desperately need some good news to turn things around. It also seems like forever ago that I decided to bank some OPTI:Optibiotix profit at 84p and move the proceeds into my trading account to double the pot. The chances of OPTI getting anywhere near 84p in the near future seem pretty slim so that ain't going to happen. I can't believe I was suckered in to believing DDDD would re-rate when they listed on Nasdaq. How wrong was that - down 40% since then!

Feeling somewhat deflated this week as I really thought things had turned around and would start going in the right direction after last week's rise, with OPTI:Optibiotix at least re-rating in the mid 50's, but nope, here we are again back in the 40's. Six years is a long time to be invested in a company and still be 20% down. My conviction hasn't wavered that this is going to be a highly profitable company, and I keep telling myself that if the price hadn't stayed this low I wouldn't have accumulated so many shares. However, now I've bought as many as I dare, so it would be wonderful to see some return.

Week 313 Review - Dreadful week saved by magnificent Optibiotix

A pretty dreadful week for the majority of the portfolio, with almost everything dropping. Fortunately the half-year update from OPTI:Optibiotix was well received and the share price increased by 6p which is worth £9,600. You can see how bad a week it was everywhere else when the deficit between cost and value only narrowed by £6,919 meaning everything else lost £2,600. The deficit stands at £27,076 and total portfolio value is up to £120,015.

Worst performer was FXPO:Ferrexpo which fell 10% after absolutely stunning results. They have vast amounts of cash and increased the dividend, and yet dropped by 10%. I will never understand the markets.

JLP:Jubilee Metals lost 6% which is a tiny drop of 0.3p. They also published stunning results this week but all my miners were bashed.

Share of the Week by miles was OPTI:Optibiotix as nearly everything else dropped, but an 8% rise may have been enough to win even in a less dreadful week. Although a really great rise, these are still 16% down after holding for 6 years. It's not been an investing success story so far, but we'll see what things look like a couple of years from now.

Back up to the level we've been at for almost 6 months.

Almost back to the trend line. Let's hope this is one of those OPTI:Optibiotix hikes. I'd be more than happy if it went up just above 60p and held there for a while.

Here's the ISA and shares portfolio after week 1 of year 7.

			Weekly Change
Cash	£31.58		-£3.75
Portfolio cost	£68,170.47		+£0
Portfolio sell value (bid price-commission)	£57,615.89	(-15.5%)	+£3,870.01
Potential profits	£6,374.08		-£150.00
Yr 7 Dividends	£0		+£0
Yr 7 Profit from sales	£0		+£0
Yr 7 projected avg monthly profit	£0	(0%)	+£0
Total Dividends	£1,343.15		+£0
Total Profit from sales	£24,123.94		+£0
Average monthly cash profit	£348.68	(9.5%)	-£1.17
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	57%		+0%

Big hike in value thanks to OPTI:Optibiotix, £150 drop in potential profits for JLP:Jubilee Metals despite amazing results, and ISA fee taken from cash. I re-set the counter for the beginning of year 7 but counted the £3,75 fee in year 6 so we don't start the year on a negative.

Nice to be closer to the cost line than the injection line again.

Almost on the trend line and the line is still pointing up, so I'm feeling more optimistic.

The SIPP looks like this after week 297 overall and week 37 of year 6.

			Weekly Change
Cash	£304.61		-£182.09
Portfolio cost	£75,951.71		+£473.40
Portfolio sell value (bid price - commission)	£60,488.85	(-20.4%)	+£3,054.43
Potential profits	£574.39		-£356.48
Yr 6 Dividends	£902.77		+£0
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£8,082.59		+£307.97
Yr 6 projected avg monthly profit	£1,034.67	(27.1%)	+£6.31
Total Dividends	£2,969.85		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£23,542.03		+£307.97
Average monthly cash profit	£375.56	(9.9%)	+£2.99
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	56%		+0%

I sold another 500 shares in CAML:Central Asia Metals at 247.3p making £307.97 (33.1%) profit. I know this is one of my favourite companies, but I still have 1,000 shares and I really needed some cash because I'm getting excited about the prospects for TLOU:Tlou Energy and think a massive re-rate is coming soon. The announcement of a deal to form a joint venture to produce hydrogen was the tipping point that made me want more. I bought 42,461 shares at 3.2454p costing £1,389.98. This takes my total holding to 110,791 costing £5,171 so it's one of my largest holdings. They seem to be doing everything right, and although there have been delays due to the Botswana government and also Covid, they are making steady progress and I can see the project being completed in the next few years.

Potential profits in my magic formula shares dropped by £50 and are almost wiped out as FXPO:Ferrexpo has gone back to loss leaving jsut ASHM:Ashmore Group on £12 and IGG:IG Group on £9, with the rest being CAML:Central Asia Metals.

Value soared thanks to OPTI:Optibiotix and the sale moved performance up a notch to 9.9% which is very pleasing.

Back to being about half way between injection and cost

Still a bit below the trend line, and with that firmly in the down direction there's a lot to do to turn this around.

The trading account looks like this after week 263 overall and week 3 of year 6.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£1,315.36	(-44.6%)	-£5.33
Potential profits	£0.00		+£0
Year 6 Dividends	£0.00		+£0
Year 6 Profit	£0.00		+£0
Yr 6 projected avg monthly profit	£0.00	(0%)	+£0
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£16.44	(8.3%)	-£0.07
(Sold stocks profit + Dividends - Fees / Months)

The drop in DDDD:4D Pharma cancelled out the small gains in HUM:Hummingbird Resources and IQE:IQE.

Just managing to stay above the injection line, so my morale isn't completely crushed yet.

Every week the trend line gets steeper in the wrong direction

I don't know what's going to happen now we've had the OPTI:Optibiotix trading statement. I think some of the previous holders that sold up are coming back, but the volume is still low and I don't think we're attracting new investors. If we continue with a trickle of buys as news gets out, then we may re-rate back into the 60's, and any Sweetbiotix news should propel us much higher, but I don't think that's coming for a while. All I can do is wait and hope.

Week 312 Review - Fairly flat with no big drops

This was a better week than most of the recent ones, with no major drops and a 1p rise in OPTI:Optibiotix contributing £1,600 of the £2,613 rise. That narrowed the deficit between cost and value to £33,995 and increased overall value to £112,808.

When I say there were no major drops, JLP:Jubilee Metals fell 14% of my purchase price, but given my purchase price was so low it's not really much of a drop in real terms.

IES:Invinity Energy climbed 5%, possibly due to news of a director buying shares, as here's no other news.

CEY:Centamin reversed the recent decline by climbing 6%, but is still 9% down, which isn't what I expect from a magic formula share.

FXPO:Ferrexpo continued to impress, with a 9% increase putting them into profit by 6% after my recent buy back in, which is how I do expect a magic formula share to perform.

Share of the Week goes to TLOU:Tlou Energy who announced a joint venture deal to produce hydrogen and gave a positive project update. My ISA holding climbed 9% of purchase price, but is still 61% down. However my SIPP holding climbed 23% of purchase price and is only 6% down.

A little tick back upwards.

Still well below the trend line so I need to claw back around £10,000 to get back above it..

Here's the ISA and shares portfolio after week 52 of year 6.

			Weekly Change
Cash	£35.33		+£0
Portfolio cost	£68,170.47		+£0
Portfolio sell value (bid price-commission)	£53,745.88	(-21.2%)	+£1,031.29
Potential profits	£6,524.08		-£300.00
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£3,697.33		+£0
Yr 6 projected avg monthly profit	£304.36	(8.3%)	-£5.97
Total Dividends	£1,343.15		+£0
Total Profit from sales	£24,123.94		+£0
Average monthly cash profit	£349.85	(9.6%)	-£1.13
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	57%		+0%

The end of Year 6 and some, but not all of last week's losses were clawed back,   but JLP:Jubilee Metals dropped £300 from potential profits. My performance for year 6 is slightly below the long term average, but when you consider that I wrote off £3,472 worth of losses in TRK:Torotrak, MAIS:Maistro, BLCC:Block Commodities and MTFB:Motif Bio during the year, finishing with an 8.3% return is pretty good. Most of my profits were from JLP:Jubilee Metals earning £7,056, with just £113 from IQE:IQE.

Long term profits of 9.6% are very close to target. It's just a shame the portfolio is 21% down at the moment, but the market is pretty bad and my bacteria shares have been hammered.

Still way closer to injection than to cost.

Only £5,000 below the trend line which is still pointing upwards, so there is hope.

The SIPP looks like this after week 296 overall and week 36 of year 6.

			Weekly Change
Cash	£486.70		+£14.16
Portfolio cost	£75,478.31		+£0
Portfolio sell value (bid price - commission)	£56,961.02	(-24.5%)	+£1,572.08
Potential profits	£930.87		+£155.35
Yr 6 Dividends	£902.77		+£14.16
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£7,774.62		+£0
Yr 6 projected avg monthly profit	£1,028.36	(27.0%)	-£27.63
Total Dividends	£2,969.85		+£14.16
Total Interest	£0.20		+£0
Total Profit from sales	£23,234.06		+£0
Average monthly cash profit	£372.57	(9.8%)	-£1.05
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	56%		+0%

There was a dividend of £14 from CMCL:Caledonia Mining helping make this a record year for dividends so far at £902. It's only just over 1% of the portfolio cost, but it's better than building society interest and I still only have a small number of dividend paying shares.

Potential profits increased by £155, including FXPO:Ferrexpo going from loss to £63 profit and IGG:IG Group going from loss to £9 profit, with the rest being a small increase in CAML:Central Asia Metals.

Projected year 6 profits are dropping rapidly now I've stopped selling, but will be best ever if I don't suffer any big losses in the next 16 weeks.

Not much of a rise really, but better than a dip.

As with the ISA, I need £5,000 to get up to the trend line, but a lot more to reverse the downward trend.

The trading account looks like this after week 262 overall and week 2 of year 6.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£1,320.69	(-44.4%)	+£10.57
Potential profits	£0.00		+£0
Year 6 Dividends	£0.00		+£0
Year 6 Profit	£0.00		+£0
Yr 6 projected avg monthly profit	£0.00	(0%)	+£0
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£16.51	(8.3%)	-£0.06
(Sold stocks profit + Dividends - Fees / Months)

A small increase this week, but we're still 44% down and still miles off selling anything.

Just bounced off the injection line.

£250 is quite a lot to get back for this account to get above the trend line and try to flip it back upwards.

We're due an H1 trading update from OPTI:Optibiotix next week. I'm a little fearful, as recent updates haven't met investor expectations and although good, have resulted in a drop in share price. I know loads of things are happening and news of big SweetBiotix deals isn't far away, but I have a feeling there's more pain to be had before that happens. I don't have any firepower to top up, so will just ride it out and keep hoping.